Lista de obras -

A Landscape of Metabolic Variation across Tumor Types

artículo científico publicado en 2018

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

artículo científico publicado en 2022

A classification model for distinguishing copy number variants from cancer-related alterations

artículo científico publicado en 2010

A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data

artículo científico publicado en 2010

A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response

artículo científico publicado en 2020

A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma

artículo científico publicado en 2020

A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract

artículo científico publicado en 2020

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

scientific article published on 10 May 2018

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network

artículo científico publicado en 2013

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.

artículo científico publicado en 2018

Aminopeptidase activities as prospective urinary biomarkers for bladder cancer

artículo científico publicado en 2014

An EM algorithm to improve the estimation of the probability of clonal relatedness of pairs of tumors in cancer patients

scientific article published on 08 November 2019

Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging.

artículo científico publicado en 2017

Assessment of SLX4 Mutations in Hereditary Breast Cancers

artículo científico publicado en 2013

Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy

artículo científico publicado en 2015

Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series

artículo científico publicado en 2019

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer

artículo científico publicado en 2016

Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype

artículo científico publicado en 2022

Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinoma

artículo científico publicado en 2019

Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma

artículo científico publicado en 2018

Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions

artículo científico publicado en 2012

Clonal relationships between lobular carcinoma in situ and other breast malignancies

artículo científico publicado en 2016

Clonality: an R package for testing clonal relatedness of two tumors from the same patient based on their genomic profiles ⬇️

artículo científico publicado el 5 de mayo de 2011

Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein

artículo científico publicado en 2013

Comparison of properties of tests for assessing tumor clonality

artículo científico publicado en 2008

Contralateral breast cancers: Independent cancers or metastases?

artículo científico publicado en 2017

DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

artículo científico publicado en 2017

Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis

artículo científico publicado en 2014

Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.

artículo científico publicado en 2016

Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

artículo científico publicado en 2017

Estimating the dose–toxicity curve in completed phase I studies ⬇️

artículo científico publicado el 22 de febrero de 2011

Estimating the probability of clonal relatedness of pairs of tumors in cancer patients

artículo científico publicado en 2017

Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder

Evaluation of the clonal origin of multiple primary melanomas using molecular profiling

artículo científico publicado en 2009

Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma

scientific article published on 01 August 2020

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.

artículo científico publicado en 2016

Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND.

scientific article published in 2014

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors

artículo científico publicado en 2016

Genome sequencing identifies a basis for everolimus sensitivity

artículo científico publicado en 2012

Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma

artículo científico publicado en 2016

Genomic Characterization of Upper Tract Urothelial Carcinoma

artículo científico publicado en 2015

Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers

artículo científico publicado en 2009

Genomic characterization of response to chemoradiation in urothelial bladder cancer

artículo científico publicado en 2016

Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma

artículo científico publicado en 2017

Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder

artículo científico publicado en 2014

Identifying prognostic pairwise relationships among bacterial species in microbiome studies

artículo científico publicado en 2021

Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma

artículo científico publicado en 2014

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

artículo científico publicado en 2022

Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma

artículo científico publicado en 2014

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

artículo científico publicado en 2015

Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma

artículo científico publicado en 2017

MP61-05 PILOT INVESTIGATION OF VARIANTS IN DNA REPAIR PATHWAYS AND ASSOCIATION WITH RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN BLADDER CANCER

Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts

artículo científico publicado en 2020

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer

article

Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission

artículo científico publicado en 2012

Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience

scientific article published on 06 March 2020

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

artículo científico publicado en 2017

Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.

artículo científico publicado en 2017

Nonenhancing Component of Clear Cell Renal Cell Carcinoma on Computed Tomography Correlates With Tumor Necrosis and Stage and Serves as a Size-Independent Prognostic Biomarker

artículo científico publicado en 2019

Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults

artículo científico publicado en 2016

Osteochondroma in long-term survivors of high-risk neuroblastoma

artículo científico publicado en 2015

PTEN Expression, Not Mutation Status for , or , Correlates With Outcome on Everolimus in Patients With Renal Cell Carcinoma Treated on RECORD-3

artículo científico publicado en 2018

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma

scientific article published on 07 January 2016

Phase II study of everolimus in metastatic urothelial cancer

artículo científico publicado en 2013

Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.

artículo científico publicado en 2013

Pilot investigation of variants in DNA repair pathways and association with response to platinum-based chemotherapy in bladder cancer

Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort

artículo científico publicado en 2020

Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer

artículo científico publicado en 2013

Prognostic Value of TERT Alterations, Mutational and Copy Number Alterations Burden in Urothelial Carcinoma

artículo científico publicado en 2017

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy

artículo científico publicado en 2013

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study

artículo científico publicado en 2015

Prospective Evaluation of Unprocessed Core Needle Biopsy DNA and RNA Yield from Lung, Liver, and Kidney Tumors: Implications for Cancer Genomics

artículo científico publicado en 2018

Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations

artículo científico publicado en 2013

Recurrent pre-existing and acquired DNA copy number alterations, including focal TERT gains, in neuroblastoma central nervous system metastases

artículo científico publicado en 2013

Reply to L. Moreno et al.

artículo científico publicado en 2013

Reply to S. Zhang et al

scientific article published on 05 September 2018

Resource-efficient pooled sequencing expands translational impact in solid tumors

artículo científico publicado en 2021

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma

artículo científico publicado en 2014

Sunitinib in urothelial cancer: clinical, pharmacokinetic, and immunohistochemical study of predictors of response.

artículo científico publicado en 2011

Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention

artículo científico publicado en 2008

Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy

artículo científico publicado en 2014

Testing clonal relatedness of tumors using array comparative genomic hybridization: a statistical challenge

artículo científico publicado en 2010

Testing clonal relatedness of two tumors from the same patient based on their mutational profiles: update of the Clonality R package

scientific article published on 01 November 2019

Testing tumors from different anatomic sites for clonal relatedness using somatic mutation data

scientific article published on 05 March 2020

The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.

artículo científico publicado en 2015

The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling

artículo científico publicado en 2014

The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma

scientific article published on 04 October 2019

The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experience

artículo científico publicado en 2015

Timing of blood transfusion and oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma.

artículo científico publicado en 2018

Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial

scientific article published on 08 January 2019

Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study

artículo científico publicado en 2019

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

artículo científico publicado en 2016

USING SOMATIC MUTATION DATA TO TEST TUMORS FOR CLONAL RELATEDNESS. ⬇️

artículo científico publicado en 2015

Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma

artículo científico publicado en 2015

When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?

artículo científico publicado en 2014

Lista de obras de

A Landscape of Metabolic Variation across Tumor Types

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

A classification model for distinguishing copy number variants from cancer-related alterations

A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data

A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response

A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma

A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.

Aminopeptidase activities as prospective urinary biomarkers for bladder cancer

An EM algorithm to improve the estimation of the probability of clonal relatedness of pairs of tumors in cancer patients

Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging.

Assessment of SLX4 Mutations in Hereditary Breast Cancers

Bone marrow minimal residual disease was an early response marker and a consistent independent predictor of survival after anti-GD2 immunotherapy

Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer

Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype

Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinoma

Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma

Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions

Clonal relationships between lobular carcinoma in situ and other breast malignancies

Clonality: an R package for testing clonal relatedness of two tumors from the same patient based on their genomic profiles ⬇️

Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein

Comparison of properties of tests for assessing tumor clonality

Contralateral breast cancers: Independent cancers or metastases?

DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis

Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.

Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Estimating the dose–toxicity curve in completed phase I studies ⬇️

Estimating the probability of clonal relatedness of pairs of tumors in cancer patients

Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder

Evaluation of the clonal origin of multiple primary melanomas using molecular profiling

Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.

Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND.

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors

Genome sequencing identifies a basis for everolimus sensitivity

Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma

Genomic Characterization of Upper Tract Urothelial Carcinoma

Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers

Genomic characterization of response to chemoradiation in urothelial bladder cancer

Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma

Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder

Identifying prognostic pairwise relationships among bacterial species in microbiome studies

Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma

MP61-05 PILOT INVESTIGATION OF VARIANTS IN DNA REPAIR PATHWAYS AND ASSOCIATION WITH RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN BLADDER CANCER

Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer

Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission

Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.

Nonenhancing Component of Clear Cell Renal Cell Carcinoma on Computed Tomography Correlates With Tumor Necrosis and Stage and Serves as a Size-Independent Prognostic Biomarker

Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults

Osteochondroma in long-term survivors of high-risk neuroblastoma

PTEN Expression, Not Mutation Status for , or , Correlates With Outcome on Everolimus in Patients With Renal Cell Carcinoma Treated on RECORD-3

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma

Phase II study of everolimus in metastatic urothelial cancer

Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.

Pilot investigation of variants in DNA repair pathways and association with response to platinum-based chemotherapy in bladder cancer

Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort

Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer

Prognostic Value of TERT Alterations, Mutational and Copy Number Alterations Burden in Urothelial Carcinoma

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study

Prospective Evaluation of Unprocessed Core Needle Biopsy DNA and RNA Yield from Lung, Liver, and Kidney Tumors: Implications for Cancer Genomics

Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations

Recurrent pre-existing and acquired DNA copy number alterations, including focal TERT gains, in neuroblastoma central nervous system metastases

Reply to L. Moreno et al.

Reply to S. Zhang et al

Resource-efficient pooled sequencing expands translational impact in solid tumors

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma

Sunitinib in urothelial cancer: clinical, pharmacokinetic, and immunohistochemical study of predictors of response.